Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study.

Bramuzzo M, Arrigo S, Romano C, Filardi MC, Lionetti P, Agrusti A, Dipasquale V, Paci M, Zuin G, Aloi M, Strisciuglio C, Miele E, Pastore M, Martelossi S, Alvisi P; SIGENP IBD Working Group.

United European Gastroenterol J. 2019 Jul;7(6):759-766. doi: 10.1177/2050640619847592. Epub 2019 Apr 25.

PMID:
31316780
2.

Clinical manifestations and gastrointestinal pathology in 40 patients with autoimmune enteropathy.

Villanacci V, Lougaris V, Ravelli A, Buscarini E, Salviato T, Lionetti P, Salemme M, Martelossi S, De Giacomo C, Falchetti D, Pelizzo G, Bassotti G.

Clin Immunol. 2019 Jul 4;207:10-17. doi: 10.1016/j.clim.2019.07.001. [Epub ahead of print]

PMID:
31279857
3.

Complicated disease and response to initial therapy predicts early surgery in paediatric Crohn's disease: results from the Porto Group GROWTH study.

Levine A, Chanchlani N, Ziv-Baran T, Escher JC, Amil Dias J, Veres G, Koletzko S, Turner D, Kolho KL, Paerregaard A, Staiano A, Lionetti P, Nuti F, Sladek M, Shaoul R, Lazowska-Prezeorek I, de Carpi JM, Sigall Boneh R, Pfeffer Gik T, Cohen-Dolev N, Russell RK; Porto Group of ESPGHAN.

J Crohns Colitis. 2019 Jun 3. pii: jjz111. doi: 10.1093/ecco-jcc/jjz111. [Epub ahead of print]

PMID:
31162532
4.

Long-term Outcomes of Paediatric Patients Admitted with Acute Severe Colitis - A Multicenter Study from the Paediatric IBD Porto Group of ESPGHAN.

Krauthammer A, Tzivinikos C, Assa A, Miele E, Strisciuglio C, Urlep D, Serban ED, Singh A, Winter HS, Russell RK, Hojsak I, Malham M, Navas-López VM, Croft NM, Lee HM, Ledder O, Shamasneh I, Hussey S, Huynh H, Wine E, Shah N, Sladek M, de Meij TG, Romano C, Dipasquale V, Lionetti P, Afzal NA, Aloi M, Lee K, Martín-de-Carpi J, Yerushalmy-Feler A, Subramanian S, Weiss B, Shouval DS.

J Crohns Colitis. 2019 May 23. pii: jjz092. doi: 10.1093/ecco-jcc/jjz092. [Epub ahead of print]

PMID:
31120524
5.

Multisystem autoimmune disease caused by increased STAT3 phosphorylation and dysregulated gene expression.

Todaro F, Tamassia N, Pinelli M, Moratto D, Dotta L, Grassi A, Consonni F, Giacomelli M, Lionetti P, Gardiman E, Cassatella MA, Gambineri E, Canani RB, Badolato R.

Haematologica. 2019 Jul;104(7):e322-e325. doi: 10.3324/haematol.2018.202374. Epub 2019 May 9. No abstract available.

6.

Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn's disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience.

Alvisi P, Arrigo S, Cucchiara S, Lionetti P, Miele E, Romano C, Ravelli A, Knafelz D, Martelossi S, Guariso G, Accomando S, Zuin G, De Giacomo C, Balzani L, Gennari M, Aloi M; SIGENP IBD Working Group.

Biologics. 2019 Jan 3;13:13-21. doi: 10.2147/BTT.S183088. eCollection 2019.

7.

Late Relapse of Henoch-Schönlein Purpura in an Adolescent Presenting as Severe Gastroduodenitis.

Rubino C, Paci M, Resti M, Lionetti P, Trapani S.

Front Pediatr. 2018 Nov 20;6:355. doi: 10.3389/fped.2018.00355. eCollection 2018.

8.

An early diagnosis of trichorhinophalangeal syndrome type 1: a case report and a review of literature.

Trippella G, Lionetti P, Naldini S, Peluso F, Monica MD, Stagi S.

Ital J Pediatr. 2018 Nov 20;44(1):138. doi: 10.1186/s13052-018-0580-z. Review.

9.

Response to treatment is more important than disease severity at diagnosis for prediction of early relapse in new-onset paediatric Crohn's disease.

Ziv-Baran T, Hussey S, Sladek M, Amil Dias J, Martin de Carpi J, Miele E, Veres G, Lionetti P, Koletzko S, Nuti F, Paerregaard A, Kolho KL, Russell RK, Shaoul R, Weiner D, Sigall Boneh R, Escher J, Finnby L, Turner D, Levine A.

Aliment Pharmacol Ther. 2018 Dec;48(11-12):1242-1250. doi: 10.1111/apt.15016. Epub 2018 Nov 18.

PMID:
30450578
10.

Quantitative Analysis of Apparent Diffusion Coefficient for Disease Assessment in Paediatric Inflammatory Bowel Disease.

Scionti A, Di Maurizio M, Basile M, Bernardini A, Miccoli M, Lionetti P, Defilippi C, Caramella D.

J Pediatr Gastroenterol Nutr. 2019 Mar;68(3):353-359. doi: 10.1097/MPG.0000000000002178.

PMID:
30358740
11.

SAPHO syndrome in pediatric patients with inflammatory bowel disease treated with infliximab.

Marrani E, Belli G, Simonini G, Trapani S, Caproni M, Lionetti P.

Dig Liver Dis. 2018 Nov;50(11):1249-1251. doi: 10.1016/j.dld.2018.09.001. Epub 2018 Sep 12. No abstract available.

PMID:
30274793
12.

Population genomics reveals evolution and variation of Saccharomyces cerevisiae in the human and insects gut.

Ramazzotti M, Stefanini I, Di Paola M, De Filippo C, Rizzetto L, Berná L, Dapporto L, Rivero D, Tocci N, Weil T, Lenucci MS, Lionetti P, Cavalieri D.

Environ Microbiol. 2019 Jan;21(1):50-71. doi: 10.1111/1462-2920.14422. Epub 2018 Nov 21.

PMID:
30246283
13.

Use of Biosimilars in Pediatric Inflammatory Bowel Disease: An Updated Position Statement of the Pediatric IBD Porto Group of ESPGHAN.

de Ridder L, Assa A, Bronsky J, Romano C, Russell RK, Afzal NA, Hauer AC, Knafelz D, Lionetti P, Strisciuglio C, Veres G, Winter H, Wolters VM, Sladek M, Vulto AG, Dias JA; Paediatric IBD Porto group of ESPGHAN.

J Pediatr Gastroenterol Nutr. 2019 Jan;68(1):144-153. doi: 10.1097/MPG.0000000000002141.

PMID:
30169454
14.

The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy.

Armuzzi A, Fiorino G, Variola A, Manetti N, Fries W, Orlando A, Maconi G, Bossa F, Cappello M, Biancone L, Cantoro L, Costa F, D'Incà R, Lionetti P, Principi M, Castiglione F, Annunziata ML, Di Sabatino A, Di Girolamo M, Terpin MM, Cortelezzi CC, Saibeni S, Amato A, Ardizzone S, Guidi L, Danese S, Massella A, Ventra A, Rizzuto G, Massari A, Perri F, Annese V; PROSIT Investigators .

Inflamm Bowel Dis. 2019 Feb 21;25(3):568-579. doi: 10.1093/ibd/izy264.

PMID:
30137352
15.

Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN.

Joosse ME, Aardoom MA, Kemos P, Turner D, Wilson DC, Koletzko S, Martin-de-Carpi J, Fagerberg UL, Spray C, Tzivinikos C, Sladek M, Shaoul R, Roma-Giannikou E, Bronsky J, Serban DE, Ruemmele FM, Garnier-Lengline H, Veres G, Hojsak I, Kolho KL, Davies IH, Aloi M, Lionetti P, Hussey S, Veereman G, Braegger CP, Trindade E, Wewer AV, Hauer AC, de Vries ACH, Sigall Boneh R, Sarbagili Shabat C, Levine A, de Ridder L; Paediatric IBD Porto group of ESPGHAN.

Aliment Pharmacol Ther. 2018 Sep;48(5):523-537. doi: 10.1111/apt.14893. Epub 2018 Jul 8.

PMID:
29984520
16.

Nutrition in Pediatric Inflammatory Bowel Disease: A Position Paper on Behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition.

Miele E, Shamir R, Aloi M, Assa A, Braegger C, Bronsky J, de Ridder L, Escher JC, Hojsak I, Kolaček S, Koletzko S, Levine A, Lionetti P, Martinelli M, Ruemmele F, Russell RK, Boneh RS, van Limbergen J, Veereman G, Staiano A.

J Pediatr Gastroenterol Nutr. 2018 Apr;66(4):687-708. doi: 10.1097/MPG.0000000000001896.

PMID:
29570147
17.

Genomic and Phenotypic Variation in Morphogenetic Networks of Two Candida albicans Isolates Subtends Their Different Pathogenic Potential.

Cavalieri D, Di Paola M, Rizzetto L, Tocci N, De Filippo C, Lionetti P, Ardizzoni A, Colombari B, Paulone S, Gut IG, Berná L, Gut M, Blanc J, Kapushesky M, Pericolini E, Blasi E, Peppoloni S.

Front Immunol. 2018 Jan 19;8:1997. doi: 10.3389/fimmu.2017.01997. eCollection 2017.

18.

Nutrition in Paediatric Inflammatory Bowel Disease: A Position Paper on Behalf of The Porto IBD Group of ESPGHAN.

Miele E, Shamir R, Aloi M, Assa A, Braegger C, Bronsky J, de Ridder L, Escher JC, Hojsak I, Kolaček S, Koletzko S, Levine A, Lionetti P, Martinelli M, Ruemmele F, Russell RK, Boneh RS, van Limbergen J, Veereman G, Staiano A.

J Pediatr Gastroenterol Nutr. 2018 Jan 29. doi: 10.1097/MPG.0000000000001896. [Epub ahead of print]

PMID:
29384890
19.

Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study.

Barzaghi F, Amaya Hernandez LC, Neven B, Ricci S, Kucuk ZY, Bleesing JJ, Nademi Z, Slatter MA, Ulloa ER, Shcherbina A, Roppelt A, Worth A, Silva J, Aiuti A, Murguia-Favela L, Speckmann C, Carneiro-Sampaio M, Fernandes JF, Baris S, Ozen A, Karakoc-Aydiner E, Kiykim A, Schulz A, Steinmann S, Notarangelo LD, Gambineri E, Lionetti P, Shearer WT, Forbes LR, Martinez C, Moshous D, Blanche S, Fisher A, Ruemmele FM, Tissandier C, Ouachee-Chardin M, Rieux-Laucat F, Cavazzana M, Qasim W, Lucarelli B, Albert MH, Kobayashi I, Alonso L, Diaz De Heredia C, Kanegane H, Lawitschka A, Seo JJ, Gonzalez-Vicent M, Diaz MA, Goyal RK, Sauer MG, Yesilipek A, Kim M, Yilmaz-Demirdag Y, Bhatia M, Khlevner J, Richmond Padilla EJ, Martino S, Montin D, Neth O, Molinos-Quintana A, Valverde-Fernandez J, Broides A, Pinsk V, Ballauf A, Haerynck F, Bordon V, Dhooge C, Garcia-Lloret ML, Bredius RG, Kałwak K, Haddad E, Seidel MG, Duckers G, Pai SY, Dvorak CC, Ehl S, Locatelli F, Goldman F, Gennery AR, Cowan MJ, Roncarolo MG, Bacchetta R; Primary Immune Deficiency Treatment Consortium (PIDTC) and the Inborn Errors Working Party (IEWP) of the European Society for Blood and Marrow Transplantation (EBMT).

J Allergy Clin Immunol. 2018 Mar;141(3):1036-1049.e5. doi: 10.1016/j.jaci.2017.10.041. Epub 2017 Dec 11.

20.

Differences in Outcomes Over Time With Exclusive Enteral Nutrition Compared With Steroids in Children With Mild to Moderate Crohn's Disease: Results From the GROWTH CD Study.

Cohen-Dolev N, Sladek M, Hussey S, Turner D, Veres G, Koletzko S, Martin de Carpi J, Staiano A, Shaoul R, Lionetti P, Amil Dias J, Paerregaard A, Nuti F, Pfeffer Gik T, Ziv-Baran T, Ben Avraham Shulman S, Sarbagili Shabat C, Sigall Boneh R, Russell RK, Levine A.

J Crohns Colitis. 2018 Feb 28;12(3):306-312. doi: 10.1093/ecco-jcc/jjx150.

PMID:
29165666
21.

Diet, Environments, and Gut Microbiota. A Preliminary Investigation in Children Living in Rural and Urban Burkina Faso and Italy.

De Filippo C, Di Paola M, Ramazzotti M, Albanese D, Pieraccini G, Banci E, Miglietta F, Cavalieri D, Lionetti P.

Front Microbiol. 2017 Oct 13;8:1979. doi: 10.3389/fmicb.2017.01979. eCollection 2017.

22.

Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort.

Bramuzzo M, Stocco G, Montico M, Arrigo S, Calvi A, Lanteri P, Costa S, Pellegrino S, Magazzù G, Barp J, Ghione S, Lionetti P, Zuin G, Fontana M, Di Chio T, Maggiore G, Lazzerini M, Lucafò M, Udina C, Pellegrin MC, Chicco A, Carrozzi M, Decorti G, Ventura A, Martelossi S.

Inflamm Bowel Dis. 2017 Oct;23(10):1810-1816. doi: 10.1097/MIB.0000000000001195.

PMID:
28817461
23.

Role of Polyethylene Glycol in the Treatment of Functional Constipation in Children.

Koppen IJN, Broekaert IJ, Wilschanski M, Papadopoulou A, Ribes-Koninckx C, Thapar N, Gottrand F, Orel R, Lionetti P, Benninga MA.

J Pediatr Gastroenterol Nutr. 2017 Oct;65(4):361-363. doi: 10.1097/MPG.0000000000001704. Review.

PMID:
28777126
24.

Enteric-coated budesonide for the induction and maintenance of remission of Crohn's disease in children.

Cohen SA, Aloi M, Arumugam R, Baker R, Bax K, Kierkuś J, Koletzko S, Lionetti P, Persson T, Eklund S.

Curr Med Res Opin. 2017 Jul;33(7):1261-1268. doi: 10.1080/03007995.2017.1313213. Epub 2017 Apr 19.

PMID:
28420280
25.

Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide.

Lazzerini M, Villanacci V, Pellegrin MC, Martelossi S, Magazzù G, Pellegrino S, Lucanto MC, Barabino A, Calvi A, Arrigo S, Lionetti P, Fontana M, Zuin G, Maggiore G, Bramuzzo M, Maschio M, Salemme M, Manenti S, Lorenzi L, Decorti G, Montico M, Ventura A.

Clin Gastroenterol Hepatol. 2017 Sep;15(9):1382-1389.e1. doi: 10.1016/j.cgh.2017.02.029. Epub 2017 Mar 7.

PMID:
28286192
26.

Surgical Management of Crohn Disease in Children: Guidelines From the Paediatric IBD Porto Group of ESPGHAN.

Amil-Dias J, Kolacek S, Turner D, Pærregaard A, Rintala R, Afzal NA, Karolewska-Bochenek K, Bronsky J, Chong S, Fell J, Hojsak I, Hugot JP, Koletzko S, Kumar D, Lazowska-Przeorek I, Lillehei C, Lionetti P, Martin-de-Carpi J, Pakarinen M, Ruemmele FM, Shaoul R, Spray C, Staiano A, Sugarman I, Wilson DC, Winter H, Kolho KL; IBD Working Group of ESPGHAN (IBD Porto Group).

J Pediatr Gastroenterol Nutr. 2017 May;64(5):818-835. doi: 10.1097/MPG.0000000000001562.

PMID:
28267075
27.

The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar.

Fiorino G, Manetti N, Armuzzi A, Orlando A, Variola A, Bonovas S, Bossa F, Maconi G, DʼIncà R, Lionetti P, Cantoro L, Fries W, Annunziata ML, Costa F, Terpin MM, Biancone L, Cortelezzi CC, Amato A, Ardizzone S, Danese S, Guidi L, Rizzuto G, Massella A, Andriulli A, Massari A, Lorenzon G, Ghione S, Kohn A, Ventra A, Annese V; PROSIT-BIO Cohort.

Inflamm Bowel Dis. 2017 Feb;23(2):233-243. doi: 10.1097/MIB.0000000000000995.

PMID:
28092307
28.

Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status.

Di Paola M, Cavalieri D, Albanese D, Sordo M, Pindo M, Donati C, Pagnini I, Giani T, Simonini G, Paladini A, Lionetti P, De Filippo C, Cimaz R.

Front Microbiol. 2016 Oct 26;7:1703. eCollection 2016.

29.

Age and Gender Affect the Composition of Fungal Population of the Human Gastrointestinal Tract.

Strati F, Di Paola M, Stefanini I, Albanese D, Rizzetto L, Lionetti P, Calabrò A, Jousson O, Donati C, Cavalieri D, De Filippo C.

Front Microbiol. 2016 Aug 3;7:1227. doi: 10.3389/fmicb.2016.01227. eCollection 2016.

30.

pANCA and ASCA in Children with IBD-Unclassified, Crohn's Colitis, and Ulcerative Colitis-A Longitudinal Report from the IBD Porto Group of ESPGHAN.

Birimberg-Schwartz L, Wilson DC, Kolho KL, Karolewska-Bochenek K, Afzal NA, Spray C, Romano C, Lionetti P, Hauer AC, Martinez-Vinson C, Veres G, Escher JC, Turner D; paediatric IBD Porto group of ESPGHAN.

Inflamm Bowel Dis. 2016 Aug;22(8):1908-14. doi: 10.1097/MIB.0000000000000784.

PMID:
27135480
31.

An international consensus report on a new algorithm for the management of infant diarrhoea.

Lo Vecchio A, Vandenplas Y, Benninga M, Broekaert I, Falconer J, Gottrand F, Lifschitz C, Lionetti P, Orel R, Papadopoulou A, Ribes-Koninckx C, Salvatore S, Shamir R, Schäppi M, Staiano A, Szajewska H, Thapar N, Wilschanski M, Guarino A.

Acta Paediatr. 2016 Aug;105(8):e384-9. doi: 10.1111/apa.13432. Epub 2016 May 27.

PMID:
27101938
32.

Functional gastro-intestinal disorder algorithms focus on early recognition, parental reassurance and nutritional strategies.

Vandenplas Y, Benninga M, Broekaert I, Falconer J, Gottrand F, Guarino A, Lifschitz C, Lionetti P, Orel R, Papadopoulou A, Ribes-Koninckx C, Ruemmele FM, Salvatore S, Shamir R, Schäppi M, Staiano A, Szajewska H, Thapar N, Wilschanski M.

Acta Paediatr. 2016 Mar;105(3):244-52. doi: 10.1111/apa.13270. Epub 2015 Dec 21. Review. Erratum in: Acta Paediatr. 2016 Aug;105(8):984.

PMID:
26584953
33.

Use of Placebo in Pediatric Inflammatory Bowel Diseases: A Position Paper From ESPGHAN, ECCO, PIBDnet, and the Canadian Children IBD Network.

Turner D, Koletzko S, Griffiths AM, Hyams J, Dubinsky M, de Ridder L, Escher J, Lionetti P, Cucchiara S, Lentze MJ, Koletzko B, van Rheenen P, Russell RK, Mack D, Veereman G, Vermeire S, Ruemmele F.

J Pediatr Gastroenterol Nutr. 2016 Jan;62(1):183-7. doi: 10.1097/MPG.0000000000001024.

PMID:
26545204
34.

Effect of Thalidomide on Clinical Remission in Children and Adolescents with Ulcerative Colitis Refractory to Other Immunosuppressives: Pilot Randomized Clinical Trial.

Lazzerini M, Martelossi S, Magazzù G, Pellegrino S, Lucanto MC, Barabino A, Calvi A, Arrigo S, Lionetti P, Lorusso M, Mangiantini F, Fontana M, Zuin G, Palla G, Maggiore G, Bramuzzo M, Pellegrin MC, Maschio M, Villanacci V, Manenti S, Decorti G, De Iudicibus S, Paparazzo R, Montico M, Ventura A.

Inflamm Bowel Dis. 2015 Aug;21(8):1739-49. doi: 10.1097/MIB.0000000000000437.

PMID:
26185909
35.

Pediatric IBD-unclassified Is Less Common than Previously Reported; Results of an 8-Year Audit of the EUROKIDS Registry.

Winter DA, Karolewska-Bochenek K, Lazowska-Przeorek I, Lionetti P, Mearin ML, Chong SK, Roma-Giannikou E, Maly J, Kolho KL, Shaoul R, Staiano A, Damen GM, de Meij T, Hendriks D, George EK, Turner D, Escher JC; Paediatric IBD Porto Group of ESPGHAN.

Inflamm Bowel Dis. 2015 Sep;21(9):2145-53. doi: 10.1097/MIB.0000000000000483.

PMID:
26164665
36.

Use of Biosimilars in Paediatric Inflammatory Bowel Disease: A Position Statement of the ESPGHAN Paediatric IBD Porto Group.

de Ridder L, Waterman M, Turner D, Bronsky J, Hauer AC, Dias JA, Strisciuglio C, Ruemmele FM, Levine A, Lionetti P; ESPGHAN Paediatric IBD Porto Group.

J Pediatr Gastroenterol Nutr. 2015 Oct;61(4):503-8. doi: 10.1097/MPG.0000000000000903.

PMID:
26154031
37.

Severe Erosive Esophagitis Associated With a Short Course of Ibuprofen.

Paci M, Chiappini E, Trapani S, Resti M, Lionetti P.

J Pediatr Gastroenterol Nutr. 2015 Jul;61(1):e1. doi: 10.1097/MPG.0b013e3182a0e0bf. No abstract available.

PMID:
26115432
38.

Long-term outcomes after elective ileocecal resection in children with active localized Crohn's disease--a multicenter European study.

Hojsak I, Kolacek S, Hansen LF, Bronsky J, Piekkala M, Lionetti P, Skaba R, Kolho KL.

J Pediatr Surg. 2015 Oct;50(10):1630-5. doi: 10.1016/j.jpedsurg.2015.03.054. Epub 2015 Apr 10.

PMID:
25913894
39.

Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms.

Stocco G, Cuzzoni E, De Iudicibus S, Favretto D, Malusà N, Martelossi S, Pozzi E, Lionetti P, Ventura A, Decorti G.

World J Gastroenterol. 2015 Mar 28;21(12):3571-8. doi: 10.3748/wjg.v21.i12.3571.

40.

Gut immune reconstitution in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome after hematopoietic stem cell transplantation.

Gambineri E, Ciullini Mannurita S, Robertson H, Vignoli M, Haugk B, Lionetti P, Hambleton S, Barge D, Gennery AR, Slatter M, Nademi Z, Flood TJ, Jackson A, Abinun M, Cant AJ.

J Allergy Clin Immunol. 2015 Jan;135(1):260-2. doi: 10.1016/j.jaci.2014.09.009. Epub 2014 Oct 25. No abstract available.

41.

Matrix expansion and syncytial aggregation of syndecan-1+ cells underpin villous atrophy in coeliac disease.

Salvestrini C, Lucas M, Lionetti P, Torrente F, James S, Phillips AD, Murch SH.

PLoS One. 2014 Sep 8;9(9):e106005. doi: 10.1371/journal.pone.0106005. eCollection 2014.

42.

ESPGHAN position paper on management of percutaneous endoscopic gastrostomy in children and adolescents.

Heuschkel RB, Gottrand F, Devarajan K, Poole H, Callan J, Dias JA, Karkelis S, Papadopoulou A, Husby S, Ruemmele F, Schäppi MG, Wilschanski M, Lionetti P, Orel R, Tovar J, Thapar N, Vandenplas Y; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

J Pediatr Gastroenterol Nutr. 2015 Jan;60(1):131-41. doi: 10.1097/MPG.0000000000000501.

PMID:
25023584
43.

Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease.

Ruemmele FM, Veres G, Kolho KL, Griffiths A, Levine A, Escher JC, Amil Dias J, Barabino A, Braegger CP, Bronsky J, Buderus S, Martín-de-Carpi J, De Ridder L, Fagerberg UL, Hugot JP, Kierkus J, Kolacek S, Koletzko S, Lionetti P, Miele E, Navas López VM, Paerregaard A, Russell RK, Serban DE, Shaoul R, Van Rheenen P, Veereman G, Weiss B, Wilson D, Dignass A, Eliakim A, Winter H, Turner D; European Crohn's and Colitis Organisation; European Society of Pediatric Gastroenterology, Hepatology and Nutrition.

J Crohns Colitis. 2014 Oct;8(10):1179-207. doi: 10.1016/j.crohns.2014.04.005. Epub 2014 Jun 6.

44.

Adalimumab in the treatment of immune-mediated diseases.

Lapadula G, Marchesoni A, Armuzzi A, Blandizzi C, Caporali R, Chimenti S, Cimaz R, Cimino L, Gionchetti P, Girolomoni G, Lionetti P, Marcellusi A, Mennini FS, Salvarani C.

Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):33-48. Review.

PMID:
24774505
45.

anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab.

Armuzzi A, Lionetti P, Blandizzi C, Caporali R, Chimenti S, Cimino L, Gionchetti P, Girolomoni G, Lapadula G, Marchesoni A, Marcellusi A, Mennini FS, Salvarani C, Cimaz R.

Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):11-32. Review.

PMID:
24774504
46.

The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases.

Blandizzi C, Gionchetti P, Armuzzi A, Caporali R, Chimenti S, Cimaz R, Cimino L, Lapadula G, Lionetti P, Marchesoni A, Marcellusi A, Mennini FS, Salvarani C, Girolomoni G.

Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):1-10. Review.

PMID:
24774503
47.

Phenotype and disease course of early-onset pediatric inflammatory bowel disease.

Aloi M, Lionetti P, Barabino A, Guariso G, Costa S, Fontana M, Romano C, Lombardi G, Miele E, Alvisi P, Diaferia P, Baldi M, Romagnoli V, Gasparetto M, Di Paola M, Muraca M, Pellegrino S, Cucchiara S, Martelossi S; SIGENP IBD Group.

Inflamm Bowel Dis. 2014 Apr;20(4):597-605. doi: 10.1097/01.MIB.0000442921.77945.09.

PMID:
24569242
48.

Management guidelines of eosinophilic esophagitis in childhood.

Papadopoulou A, Koletzko S, Heuschkel R, Dias JA, Allen KJ, Murch SH, Chong S, Gottrand F, Husby S, Lionetti P, Mearin ML, Ruemmele FM, Schäppi MG, Staiano A, Wilschanski M, Vandenplas Y; ESPGHAN Eosinophilic Esophagitis Working Group and the Gastroenterology Committee.

J Pediatr Gastroenterol Nutr. 2014 Jan;58(1):107-18. doi: 10.1097/MPG.0b013e3182a80be1.

PMID:
24378521
49.

Malignancy and mortality in pediatric patients with inflammatory bowel disease: a multinational study from the porto pediatric IBD group.

de Ridder L, Turner D, Wilson DC, Koletzko S, Martin-de-Carpi J, Fagerberg UL, Spray C, Sladek M, Shaoul R, Roma-Giannikou E, Bronsky J, Serban DE, Cucchiara S, Veres G, Ruemmele FM, Hojsak I, Kolho KL, Davies IH, Aloi M, Lionetti P, Veereman-Wauters G, Braegger CP, Trindade E, Wewer AV, Hauer A, Levine A; Porto IBD Working Group of ESPGHAN.

Inflamm Bowel Dis. 2014 Feb;20(2):291-300. doi: 10.1097/01.MIB.0000439066.69340.3c.

50.

Effect of thalidomide on clinical remission in children and adolescents with refractory Crohn disease: a randomized clinical trial.

Lazzerini M, Martelossi S, Magazzù G, Pellegrino S, Lucanto MC, Barabino A, Calvi A, Arrigo S, Lionetti P, Lorusso M, Mangiantini F, Fontana M, Zuin G, Palla G, Maggiore G, Bramuzzo M, Pellegrin MC, Maschio M, Villanacci V, Manenti S, Decorti G, De Iudicibus S, Paparazzo R, Montico M, Ventura A.

JAMA. 2013 Nov 27;310(20):2164-73. doi: 10.1001/jama.2013.280777.

PMID:
24281461

Supplemental Content

Loading ...
Support Center